主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AVDL
#1626
Avadel Pharmaceuticals plc
21.640
0
+0.05%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.05%
每月变动
+0.70%
6个月变化
+16.66%
年变化
+16.66%
前一天收盘价
21.630
0
Open
21.640
0
Bid
Ask
Low
21.640
0
High
21.640
0
交易量
1 054
市场
股票
医疗保健
AVDL
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
新闻
Alkermes财报即将公布,睡眠障碍治疗战略逐渐成形
Alkermes earnings up next as sleep strategy takes shape
Harmony Biosciences Makes The Grade (NASDAQ:HRMY)
UBS上调Alkermes目标价至47美元,此前为46美元,因Avadel交易
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal
贝莱德披露持有Avadel制药6.94%股份
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals
TIG Advisors披露持有Avadel制药4.18%股权
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals
高盛披露在Avadel制药的交易头寸
Goldman Sachs discloses trading position in Avadel Pharmaceuticals
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals